Hanvon(SZ:002362) Zheng Quan Shi Bao Wang·2025-09-19 12:09Core Insights - Hanwang Technology launched the KSY3610 and KSY8600 electronic blood pressure monitors, emphasizing affordability and advanced features like atrial fibrillation screening [1][2] - The pricing strategy of KSY3610 starts at 259 yuan, aiming to make high-end blood pressure monitoring technology accessible to a broader market [1][2] - The company promotes a philosophy of "technology for all," seeking to provide high-quality health monitoring devices at reasonable prices [1][2] Company Strategy - Hanwang's ability to offer "high functionality at low prices" stems from its advancements in artificial intelligence and sensor technology [2] - The KSY3610 utilizes dual sensors and AI algorithms to accurately measure blood pressure by detecting Korotkoff sounds, matching the precision of traditional mercury sphygmomanometers [2] - The integration of atrial fibrillation screening in KSY3610 allows for comprehensive health risk assessments during a single measurement [2] Market Trends - The market for electronic blood pressure monitors is expanding due to regulatory changes, such as the ban on mercury-containing devices starting January 1, 2026 [3] - Data indicates a trend of home medical devices becoming more prevalent, with a projected compound annual growth rate of 18.6% in the blood pressure monitor sector from 2022 to 2025 [3] - Hanwang's product launch reflects a strategic intent to reshape the industry value system by making medical-grade monitoring technology available in the consumer market [3]